comparemela.com

Latest Breaking News On - University of toronto institute health - Page 3 : comparemela.com

Was it luck — or was New Brunswick actually quite good at responding to COVID-19?

Was it luck — or was New Brunswick actually quite good at responding to COVID-19?
cbc.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cbc.ca Daily Mail and Mail on Sunday newspapers.

Expert says COVID-19 safety claims in leaked B C school report not valid as teachers urge hybrid learning

A leaked presentation from the province’s biggest health authority contains never-before-seen details that have the BC Teachers Federation calling for a switch to hybrid learning in COVID-19 hot spots.

With a health equity lens, University of Toronto researcher leads study focused on diabetes-related vision loss

Date Time Share With a health equity lens, University of Toronto researcher leads study focused on diabetes-related vision loss The University of Toronto’s Aleksandra Stanimirovic is currently leading a study that, she says, underscores the reason she chose to become a health researcher as opposed to a physician. The project focuses on a screening program for diabetic retinopathy – a complication of diabetes that can lead to blindness – among women from lower socio-economic groups. She hopes her work will help affected women detect changes in their vision early so they can receive appropriate care. “I thought as a clinician, my impact is somewhat limited to my patients, whereas with the research I’m doing now, for example, which is focused on policy change, my impact can be further reaching,” says Stanimirovic, now a post-doctoral researcher at the University of Toronto’s Institute of Health Policy, Management and Evaluation (IHPME) at the Dalla Lana School of Pu

Statins May Protect Chemotherapy-induced Cardiac Damage

Statins May Protect Chemotherapy-induced Cardiac Damage by Angela Mohan on  January 8, 2021 at 12:16 PM Journal of the American Heart Association. Two types of cancer medications, anthracyclines and trastuzumab, are effective treatments for many women with breast cancer, however, the risk of heart muscle damage has limited their use, particularly in women who are at higher risk for heart problems because of their age or other medical issues, said Husam Abdel-Qadir, M.D., Ph.D., lead author of the study, assistant professor of medicine at the University of Toronto s Institute of Health Policy, Management and Evaluation, and a cardiologist at Women s College Hospital and the Peter Munk Cardiac Centre, part of the University Health Network in Toronto.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.